Juvenile rats in the forced-swim test model the human response to antidepressant treatment for pediatric depression

Psychopharmacology

Volumn 197, Issue 3, 2008, Pages 433-441

  Reed, Abbey L ^a   Happe, H Kevin ^b,c   Petty, Frederick ^b,c   Bylund, David B ^a  

^a NEBRASKA MEDICAL CENTER   (United States)

^b CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VA NEBRASKA WESTERN IOWA HEALTH CARE SYSTEM   (United States)

Author keywords

Animal models of depression; Forced swim test (FST); Juvenile rats; Major depressive disorder (MDD); Pediatric depression; Selective serotonin reuptake inhibitors (SSRIs); Tricyclic antidepressants (TCAs)

Indexed keywords

DESIPRAMINE; ESCITALOPRAM; FLUOXETINE; IMIPRAMINE; TRANYLCYPROMINE;

ADOLESCENT; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR CHANGE; CONTROLLED STUDY; DEPRESSION; DRUG EFFICACY; DRUG IDENTIFICATION; DRUG RESPONSE; FORCED SWIMMING TEST; IMMOBILIZATION; MALE; NONHUMAN; PREDICTION; PRIORITY JOURNAL; RAT; RELIABILITY;

ADOLESCENT; AGE FACTORS; ANIMALS; ANTIDEPRESSIVE AGENTS; CHILD; CITALOPRAM; DEPRESSIVE DISORDER; DESIPRAMINE; DISEASE MODELS, ANIMAL; ESCAPE REACTION; FLUOXETINE; HELPLESSNESS, LEARNED; HUMANS; IMIPRAMINE; INJECTIONS, INTRAPERITONEAL; MALE; MOTIVATION; RATS; RATS, SPRAGUE-DAWLEY; SWIMMING; TRANYLCYPROMINE;

EID: 43149090317     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-007-1052-0     Document Type: Article

References (49)

1. Ansorge MS, Zhou M, Lira A, Hen R, Gingrich JA (2004) Early-life blockade of the 5-HT transporter alters emotional behavior in adult mice. Science 306:879-881
2. Birmaher B (1998) Should we use antidepressant medications for children and adolescents with depressive disorders. Psychopharmacol Bull 34:35-39
3. Birmaher B, Ryan ND, Williamson DE, Brent DA, Kaufman J (1996) Childhood and adolescent depression: a review of the past 10 years. Part II. J Am Acad Child Adolesc Psychiatry 35:1575-1583
4. Brent DA, Birmaher B (2002) Clinical practice. Adolescent depression. N Engl J Med 347:667-671
5. Brunello N, Mendlewicz J, Kasper S, Leonard B, Montgomery S, Nelson J, Paykel E, Versiani M, Racagni G (2002) The role of noradrenaline and selective noradrenaline reuptake inhibition in depression. Eur Neuropsychopharmacol 12:461-475
6. Carlezon WA, Pliakas AM, Parow AM, Detke MJ, Cohen BM, Renshaw PF (2002) Antidepressant-like effects of cytidine in the forced swim test in rats. Biol Psychiatry 51:882-889
7. Cryan JF, Lucki I (2000) Antidepressant-like behavioral effects mediated by 5-Hydroxytryptamine(2C) receptors? J Pharmacol Exp Ther 295:1120-1126
8. Cryan JF, Markou A, Lucki I (2002) Assessing antidepressant activity in rodents: recent developments and future needs. Trends Pharmacol sSci 23:238-245
9. Cryan JF, Page ME, Lucki I (2005) Differential behavioral effects of the antidepressants reboxetine, fluoxetine, and moclobemide in a modified forced swim test following chronic treatment. Psychopharmacology (Berl) 182:335-344
10. Detke MJ, Lucki I (1996) Detection of serotonergic and noradrenergic antidepressants in the rat forced swimming test: the effects of water depth. Behav Brain Res 73:43-46
11. Detke MJ, Rickels M, Lucki I (1995) Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology (Berl) 121:66-72
12. Deupree JD, Reed AL, Bylund DB (2007) Differential effects of the tricyclic antidepressant desipramine on the density of adrenergic receptors in juvenile and adult rats. J Pharmacol Exp Ther 321:770-776
13. Duncan GE, Knapp DJ, Johnson KB, Breese GR (1996) Functional classification of antidepressants based on antagonism of swim stress-induced fos-like immunoreactivity. J Pharmacol Exp Ther 277:1076-1089
14. Emslie GJ, Rush AJ, Weinberg WA, Kowatch RA, Hughes CW, Carmody T, Rintelmann J (1997) A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression. Arch Gen Psychiatry 54:1031-1037
15. Emslie GJ, Ryan ND, Wagner KD (2005) Major depressive disorder in children and adolescents: clinical trial design and antidepressant efficacy. J Clin Psychiatry 66(Suppl 7):14-20
16. Geller B, Cooper TB, Graham DL, Marsteller FA, Bryant DM (1990) Double-blind placebo-controlled study of nortriptyline in depressed adolescents using a "fixed plasma level" design. Psychopharmacol Bull 26:85-90
17. Geller B, Cooper TB, Graham DL, Fetner HH, Marsteller FA, Wells JM (1992) Pharmacokinetically designed double-blind placebo-controlled study of nortriptyline in 6- to 12-year-olds with major depressive disorder. J Am Acad Child Adolesc Psychiatry 31:34-44
18. Gorka Z, Wojtasik E, Kwiatek H, Maj J (1979) Action of serotoninmimetics in the behavioral despair test in rats. Commun Psychopharmacol 3:133-136
19. Hemby SE, Lucki I, Gatto G, Singh A, Thornley C, Matasi J, Kong N, Smith JE, Davies HM, Dworkin SI (1997) Potential antidepressant effects of novel tropane compounds, selective for serotonin or dopamine transporters. J Pharmacol Exp Ther 282:727-733
20. Hooks MS, Jones DN, Holtzman SG, Juncos JL, Kalivas PW, Justice JB Jr. (1994) Individual differences in behavior following amphetamine, GBR-12909, or apomorphine but not SKF-38393 or quinpirole. Psychopharmacology (Berl) 116:217-225
21. Kessler RC, Avenevoli S, Ries MK (2001) Mood disorders in children and adolescents: an epidemiologic perspective. Biol Psychiatry 49:1002-1014
22. Kovacs M, Goldston D, Gatsonis C (1993) Suicidal behaviors and childhood-onset depressive disorders: a longitudinal investigation. J Am Acad Child Adolesc Psychiatry 32:8-20
23. Kozisek ME, Deupree JD, Burke WJ, Bylund DB (2007) Appropriate dosing regimens for treating juvenile rats with desipramine for neuropharmacological and behavioral studies. J Neurosci Methods 163:83-91
24. Kutcher S, Boulos C, Ward B, Marton P, Simeon J, Ferguson HB, Szalai J, Katic M, Roberts N, Dubois C (1994) Response to desipramine treatment in adolescent depression: a fixed-dose, placebo-controlled trial. J Am Acad Child Adolesc Psychiatry 33:686-694
25. Kye CH, Waterman GS, Ryan ND, Birmaher B, Williamson DE, Iyengar S, Dachille S (1996) A randomized, controlled trial of amitriptyline in the acute treatment of adolescent major depression. J Am Acad Child Adolesc Psychiatry 35:1139-1144
26. Leonard BE (2001) Stress, norepinephrine and depression. J Psychiatry Neurosci 26(Suppl):S11-S16
27. Lucki I, O'Leary OF (2004) Distinguishing roles for norepinephrine and serotonin in the behavioral effects of antidepressant drugs. J Clin Psychiatry 65(Suppl 4):11-24
28. Maciag D, Simpson KL, Coppinger D, Lu Y, Wang Y, Lin RCS, Paul IA (2005) Neonatal antidepressant exposure has lasting effects on behavior and serotonin circuitry. Neuropsychopharmacology 31:47-57
29. Mague SD, Pliakas AM, Todtenkopf MS, Tomasiewicz HC, Zhang Y, Stevens WC Jr., Jones RM, Portoghese PS, Carlezon WA Jr (2003) Antidepressant-like effects of kappa-opioid receptor antagonists in the forced swim test in rats. J Pharmacol Exp Ther 305:323-330
30. Maj J, Rogoz Z, Skuza G (1992) The effects of combined treatment with MK-801 and antidepressant drugs in the forced swimming test in rats. Pol J Pharmacol Pharm 44:217-226
31. March J, Silva S, Petrycki S, Curry J, Wells K, Fairbank J, Burns B, Domino M, McNulty S, Vitiello B, Severe J (2004) Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial. JAMA 292:807-820
32. McCauley E, Myers K, Mitchell J, Calderon R, Schloredt K, Treder R (1993) Depression in young people: initial presentation and clinical course. J Am Acad Child Adolesc Psychiatry 32:714-722
33. Murrin LC, Sanders JD, Bylund DB (2007) Comparison of the maturation of the adrenergic and serotonergic neurotransmitter systems in the brain: implications for differential drug effects on juveniles and adults. Biochem Pharmacol 73:1225-1236
34. Negishi T, Kawasaki K, Suzaki S, Maeda H, Ishii Y, Kyuwa S, Kuroda Y, Yoshikawa Y (2004) Behavioral alterations in response to fear-provoking stimuli and tranylcypromine induced by perinatal exposure to bisphenol A and nonylphenol in male rats. Environ Health Perspect 112:1159-1164
35. Owens MJ, Morgan WN, Plott SJ, Nemeroff CB (1997) Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites. J Pharmacol Exp Ther 283:1305-1322
36. Paul IA, Duncan GE, Kuhn C, Mueller RA, Hong JS, Breese GR (1990) Neural adaptation in imipramine-treated rats processed in forced swim test: assessment of time course, handling, rat strain and amine uptake. J Pharmacol Exp Ther 252:997-1005
37. Porsolt RD, Anton G, Blavet N, Jalfre M (1978) Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur J Pharmacol 47:379-391
38. Porsolt RD, Le PM, Jalfre M (1977) Depression: a new animal model sensitive to antidepressant treatments. Nature 266:730-732
39. Reneric JP, Lucki I (1998) Antidepressant behavioral effects by dual inhibition of monoamine reuptake in the rat forced swimming test. Psychopharmacology (Berl) 136:190-197
40. Russo-Neustadt A, Ha T, Ramirez R, Kesslak JP (2001) Physical activity-antidepressant treatment combination: impact on brain-derived neurotrophic factor and behavior in an animal model. Behav Brain Res 120:87-95
41. Sanders JD, Happe HK, Bylund DB, Murrin LC (2005) Development of the norepinephrine transporter in the rat CNS. Neuroscience 130:107-117
42. Schindler CW, Carmona GN (2002) Effects of dopamine agonists and antagonists on locomotor activity in male and female rats. Pharmacol Biochem Behav 72:857-863
43. Shaw AM, Boules M, Zhang Y, Williams K, Robinson J, Carlier PR, Richelson E (2007) Antidepressant-like effects of novel triple reuptake inhibitors, PRC025 and PRC050. Eur J Pharmacol 555:30-36
44. Slattery DA, Desrayaud S, Cryan JF (2005) GABAB receptor antagonist-mediated antidepressant-like behavior is serotonin-dependent. J Pharmacol Exp Ther 312:290-296
45. Takahashi H, Takada Y, Nagai N, Urano T, Takada A (2000) Serotonergic neurons projecting to hippocampus activate locomotion. Brain Res 869:194-202
46. Torregrossa MM, Folk JE, Rice KC, Watson SJ, Woods JH (2005) Chronic administration of the delta opioid receptor agonist ()BW373U86 and antidepressants on behavior in the forced swim test and BDNF mRNA expression in rats. Psychopharmacology (Berl) 183:31-40
47. Wagner KD, Ambrosini P, Rynn M, Wohlberg C, Yang R, Greenbaum MS, Childress A, Donnelly C, Deas D (2003) Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder: two randomized controlled trials. JAMA 290:1033-1041
48. Weissman MM, Wolk S, Goldstein RB, Moreau D, Adams P, Greenwald S, Klier CM, Ryan ND, Dahl RE, Wickramaratne P (1999a) Depressed adolescents grown up. JAMA 281:1707-1713
49. Weissman MM, Wolk S, Wickramaratne P, Goldstein RB, Adams P, Greenwald S, Ryan ND, Dahl RE, Steinberg D (1999b) Children with prepubertal-onset major depressive disorder and anxiety grown up. Arch Gen psychiatry 56:794-801